Panel Discussion: Overcoming Design Challenges in Next-Generation Oligonucleotides to Maximize Selectivity, Potency & Clinical Impact
- What design strategies are most effective in mitigating off-target effects?
- How do teams prioritize stability vs. delivery vs. potency?
- What are the emerging trends in oligonucleotide chemistry for next-generation therapeutics?